Half-life profile

MDMB-class synthetic cannabinoids half-life calculator

Educational first-order elimination curve using an approximate half-life estimate. This is not medical advice and does not predict impairment or laboratory outcomes.

Category: synthetic-cannabinoid · Updated: 2026-01-18

Now estimated in body: 0.39 mg(0.4% of starting amount)Half-life used: 3.0 h

Pharmacokinetics at a glance

Summary Educational half-life profile for MDMB-class synthetic cannabinoids (synthetic-cannabinoid). Uses a mean half-life of 3.0 hours for a simplified curve.
Mean half-life 3 hours

Summary: Educational half-life profile for MDMB-class synthetic cannabinoids (synthetic-cannabinoid). Uses a mean half-life of 3.0 hours for a simplified curve.

Half-life note: Mean terminal half-life reported in published pharmacokinetic studies. Values vary by population, dose, route, and analytic method.

Notes

Overview

MDMB-class synthetic cannabinoids is listed here as synthetic-cannabinoid. Synthetic cannabinoids are a broad class with diverse chemistry. Reported half-life values vary across compounds and study designs; this page uses a simplified educational model.

This page provides an educational visualization of exponential decay based on a single half-life estimate. It is not medical advice.

Half-life used on this page

HalfLifeDB uses a mean half-life of 3.0 hours to generate the curve below. The curve shows a relative amount remaining in a simplified model.

Half-life note: Mean terminal half-life reported in published pharmacokinetic studies. Values vary by population, dose, route, and analytic method.

What the curve represents

The calculator assumes a one-compartment, first-order elimination model after a single starting amount. In that model, the remaining amount halves every half-life interval. The curve is best used to understand the shape of exponential decline.

Why published half-life values differ

Even when a study reports a single half-life number, values can differ across studies and people. Common drivers include:

  • Route and formulation: immediate vs extended release, oral vs inhaled vs injected, and co-administered ingredients.
  • Study design: sampling window, analytic sensitivity, and how the terminal phase is defined.
  • Individual biology: age, genetics, body composition, and liver and kidney function.
  • Interactions: other medications and substances can inhibit or induce metabolism.

How to use this page

  • Use the calculator to visualize how quickly a half-life process decays over time.
  • Use the source links to see the context for the half-life estimate.
  • Treat this curve as a conceptual model, not a personal prediction.

What this page does not do

  • It does not provide dosing guidance or treatment advice.
  • It does not estimate impairment or functional safety.
  • It does not predict laboratory outcomes.

If you have questions about medication use or health decisions, consult a licensed clinician. In an emergency, contact local emergency services.

Read the full medical disclaimer and editorial policy.